Home › Compare › IGF-1 LR3 vs IGF-1 DES
IGF-1 LR3 vs IGF-1 DES
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
IGF-1 LR3Muscle / Growth
IGF-1 DESMuscle / GrowthAt a glance
| IGF-1 LR3 | IGF-1 DES | |
|---|---|---|
| Category | Muscle / Growth | Muscle / Growth |
| Typical route | SubQ | SubQ (target muscle) |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Muscle hyperplasia Recovery Fat metabolism | Local muscle growth Hyperplasia Recovery |
| Reported considerations | Hypoglycemia risk Organ growth if abused | Localized swelling Hypoglycemia risk |
The differences that actually matter
Both are classed as Muscle / Growth peptides, so they get compared constantly and are often researched for overlapping reasons.
Route of administration differs — IGF-1 LR3 is typically subq, IGF-1 DES is typically subq (target muscle). That alone changes how convenient each one is to keep up with.
Where they overlap: muscle hyperplasia, recovery.
Reported mainly for IGF-1 LR3: fat metabolism.
What IGF-1 LR3 is
IGF-1 LR3, or Long R3 Insulin-like Growth Factor-1, is a modified analog of native human IGF-1 designed for an extended half-life and enhanced bioavailability. It primarily exerts its effects by binding to the IGF-1 receptor, a transmembrane tyrosine kinase receptor, which then initiates intracellular signaling cascades, notably the PI3K/Akt and MAPK pathways, critical for cell growth, proliferation, and differentiation. The "LR3" modification involves an arginine substitution at position 3 and a 13 amino acid N-te
What IGF-1 DES is
IGF-1 DES is a modified version of insulin-like growth factor 1, specifically truncated to remove the first three amino acids (Gly-Pro-Glu) from the N-terminus. This structural change significantly reduces its affinity for insulin-like growth factor binding proteins (IGFBPs), which normally sequester IGF-1 and regulate its systemic bioavailability. Consequently, IGF-1 DES exhibits increased local activity and a shorter systemic half-life compared to native IGF-1, as it is less bound by IGFBPs and more readily avail
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — IGF-1 LR3 and IGF-1 DES are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between IGF-1 LR3 and IGF-1 DES?
Both are classed as Muscle / Growth peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log IGF-1 LR3 and IGF-1 DES in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, IGF-1 LR3 or IGF-1 DES?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.